HENRY SCHEIN INC (HSIC) Fundamental Analysis & Valuation

NASDAQ:HSIC • US8064071025

75.57 USD
+0.6 (+0.8%)
At close: Mar 13, 2026
75.57 USD
0 (0%)
After Hours: 3/13/2026, 5:20:02 PM

This HSIC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall HSIC gets a fundamental rating of 4 out of 10. We evaluated HSIC against 101 industry peers in the Health Care Providers & Services industry. HSIC has a medium profitability rating, but doesn't score so well on its financial health evaluation. HSIC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. HSIC Profitability Analysis

1.1 Basic Checks

  • In the past year HSIC was profitable.
  • In the past year HSIC had a positive cash flow from operations.
  • In the past 5 years HSIC has always been profitable.
  • Each year in the past 5 years HSIC had a positive operating cash flow.
HSIC Yearly Net Income VS EBIT VS OCF VS FCFHSIC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

1.2 Ratios

  • HSIC has a better Return On Assets (3.55%) than 68.32% of its industry peers.
  • HSIC's Return On Equity of 12.27% is amongst the best of the industry. HSIC outperforms 80.20% of its industry peers.
  • With a decent Return On Invested Capital value of 6.61%, HSIC is doing good in the industry, outperforming 66.34% of the companies in the same industry.
  • HSIC had an Average Return On Invested Capital over the past 3 years of 6.73%. This is below the industry average of 8.98%.
Industry RankSector Rank
ROA 3.55%
ROE 12.27%
ROIC 6.61%
ROA(3y)3.77%
ROA(5y)5%
ROE(3y)11.71%
ROE(5y)13.84%
ROIC(3y)6.73%
ROIC(5y)8.18%
HSIC Yearly ROA, ROE, ROICHSIC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.02%, HSIC is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
  • In the last couple of years the Profit Margin of HSIC has declined.
  • HSIC's Operating Margin of 5.79% is fine compared to the rest of the industry. HSIC outperforms 66.34% of its industry peers.
  • HSIC's Operating Margin has been stable in the last couple of years.
  • With a Gross Margin value of 31.14%, HSIC perfoms like the industry average, outperforming 58.42% of the companies in the same industry.
  • HSIC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.79%
PM (TTM) 3.02%
GM 31.14%
OM growth 3Y-5.84%
OM growth 5Y0.67%
PM growth 3Y-10.8%
PM growth 5Y-5.44%
GM growth 3Y0.92%
GM growth 5Y2.29%
HSIC Yearly Profit, Operating, Gross MarginsHSIC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

3

2. HSIC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HSIC is destroying value.
  • The number of shares outstanding for HSIC has been reduced compared to 1 year ago.
  • HSIC has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, HSIC has a worse debt to assets ratio.
HSIC Yearly Shares OutstandingHSIC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
HSIC Yearly Total Debt VS Total AssetsHSIC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • HSIC has an Altman-Z score of 2.59. This is not the best score and indicates that HSIC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.59, HSIC perfoms like the industry average, outperforming 59.41% of the companies in the same industry.
  • HSIC has a debt to FCF ratio of 5.96. This is a neutral value as HSIC would need 5.96 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 5.96, HSIC perfoms like the industry average, outperforming 57.43% of the companies in the same industry.
  • HSIC has a Debt/Equity ratio of 0.95. This is a neutral value indicating HSIC is somewhat dependend on debt financing.
  • HSIC has a Debt to Equity ratio (0.95) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 5.96
Altman-Z 2.59
ROIC/WACC0.83
WACC7.99%
HSIC Yearly LT Debt VS Equity VS FCFHSIC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that HSIC should not have too much problems paying its short term obligations.
  • HSIC has a Current ratio (1.38) which is comparable to the rest of the industry.
  • HSIC has a Quick Ratio of 1.38. This is a bad value and indicates that HSIC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HSIC has a worse Quick ratio (0.76) than 77.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.76
HSIC Yearly Current Assets VS Current LiabilitesHSIC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

4

3. HSIC Growth Analysis

3.1 Past

  • HSIC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.85%.
  • HSIC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.85% yearly.
  • The Revenue has been growing slightly by 4.03% in the past year.
  • HSIC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.43% yearly.
EPS 1Y (TTM)4.85%
EPS 3Y1.45%
EPS 5Y10.85%
EPS Q2Q%12.61%
Revenue 1Y (TTM)4.03%
Revenue growth 3Y1.4%
Revenue growth 5Y5.43%
Sales Q2Q%7.71%

3.2 Future

  • Based on estimates for the next years, HSIC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.69% on average per year.
  • HSIC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.97% yearly.
EPS Next Y9.23%
EPS Next 2Y10.16%
EPS Next 3Y9.78%
EPS Next 5Y8.69%
Revenue Next Year4.82%
Revenue Next 2Y4.22%
Revenue Next 3Y4.02%
Revenue Next 5Y3.97%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HSIC Yearly Revenue VS EstimatesHSIC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
HSIC Yearly EPS VS EstimatesHSIC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

5

4. HSIC Valuation Analysis

4.1 Price/Earnings Ratio

  • HSIC is valuated correctly with a Price/Earnings ratio of 15.21.
  • Compared to the rest of the industry, the Price/Earnings ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 79.21% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.71, HSIC is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 13.92, the valuation of HSIC can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HSIC indicates a rather cheap valuation: HSIC is cheaper than 81.19% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, HSIC is valued a bit cheaper.
Industry RankSector Rank
PE 15.21
Fwd PE 13.92
HSIC Price Earnings VS Forward Price EarningsHSIC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • HSIC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HSIC is cheaper than 71.29% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 69.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.64
EV/EBITDA 10.03
HSIC Per share dataHSIC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • HSIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.65
PEG (5Y)1.4
EPS Next 2Y10.16%
EPS Next 3Y9.78%

0

5. HSIC Dividend Analysis

5.1 Amount

  • No dividends for HSIC!.
Industry RankSector Rank
Dividend Yield 0%

HSIC Fundamentals: All Metrics, Ratios and Statistics

HENRY SCHEIN INC

NASDAQ:HSIC (3/13/2026, 5:20:02 PM)

After market: 75.57 0 (0%)

75.57

+0.6 (+0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-04
Inst Owners93.03%
Inst Owner Change-4.26%
Ins Owners0.8%
Ins Owner Change9.14%
Market Cap8.67B
Revenue(TTM)13.18B
Net Income(TTM)398.00M
Analysts73.91
Price Target80.8 (6.92%)
Short Float %4.91%
Short Ratio3.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.42%
Min EPS beat(2)1.07%
Max EPS beat(2)5.78%
EPS beat(4)3
Avg EPS beat(4)-0.28%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)5
Avg EPS beat(8)0.41%
EPS beat(12)6
Avg EPS beat(12)-0.67%
EPS beat(16)7
Avg EPS beat(16)-0.67%
Revenue beat(2)1
Avg Revenue beat(2)0.29%
Min Revenue beat(2)-0.09%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.15%
Min Revenue beat(4)-3.77%
Max Revenue beat(4)0.67%
Revenue beat(8)1
Avg Revenue beat(8)-2.81%
Revenue beat(12)1
Avg Revenue beat(12)-2.86%
Revenue beat(16)1
Avg Revenue beat(16)-2.9%
PT rev (1m)1.89%
PT rev (3m)2.66%
EPS NQ rev (1m)-4.98%
EPS NQ rev (3m)-4.9%
EPS NY rev (1m)0.44%
EPS NY rev (3m)0.62%
Revenue NQ rev (1m)0.77%
Revenue NQ rev (3m)0.86%
Revenue NY rev (1m)1.37%
Revenue NY rev (3m)1.44%
Valuation
Industry RankSector Rank
PE 15.21
Fwd PE 13.92
P/S 0.66
P/FCF 16.64
P/OCF 12.17
P/B 2.67
P/tB N/A
EV/EBITDA 10.03
EPS(TTM)4.97
EY6.58%
EPS(NY)5.43
Fwd EY7.18%
FCF(TTM)4.54
FCFY6.01%
OCF(TTM)6.21
OCFY8.21%
SpS114.94
BVpS28.29
TBVpS-17.31
PEG (NY)1.65
PEG (5Y)1.4
Graham Number56.25
Profitability
Industry RankSector Rank
ROA 3.55%
ROE 12.27%
ROCE 9.57%
ROIC 6.61%
ROICexc 6.73%
ROICexgc 17.19%
OM 5.79%
PM (TTM) 3.02%
GM 31.14%
FCFM 3.95%
ROA(3y)3.77%
ROA(5y)5%
ROE(3y)11.71%
ROE(5y)13.84%
ROIC(3y)6.73%
ROIC(5y)8.18%
ROICexc(3y)6.85%
ROICexc(5y)8.33%
ROICexgc(3y)17.53%
ROICexgc(5y)20.16%
ROCE(3y)9.53%
ROCE(5y)11.26%
ROICexgc growth 3Y-9.25%
ROICexgc growth 5Y-2.87%
ROICexc growth 3Y-13.61%
ROICexc growth 5Y-4.22%
OM growth 3Y-5.84%
OM growth 5Y0.67%
PM growth 3Y-10.8%
PM growth 5Y-5.44%
GM growth 3Y0.92%
GM growth 5Y2.29%
F-Score4
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 5.96
Debt/EBITDA 2.86
Cap/Depr 61.41%
Cap/Sales 1.45%
Interest Coverage 5.06
Cash Conversion 66.23%
Profit Quality 130.91%
Current Ratio 1.38
Quick Ratio 0.76
Altman-Z 2.59
F-Score4
WACC7.99%
ROIC/WACC0.83
Cap/Depr(3y)66.59%
Cap/Depr(5y)56.55%
Cap/Sales(3y)1.48%
Cap/Sales(5y)1.17%
Profit Quality(3y)125.21%
Profit Quality(5y)113.92%
High Growth Momentum
Growth
EPS 1Y (TTM)4.85%
EPS 3Y1.45%
EPS 5Y10.85%
EPS Q2Q%12.61%
EPS Next Y9.23%
EPS Next 2Y10.16%
EPS Next 3Y9.78%
EPS Next 5Y8.69%
Revenue 1Y (TTM)4.03%
Revenue growth 3Y1.4%
Revenue growth 5Y5.43%
Sales Q2Q%7.71%
Revenue Next Year4.82%
Revenue Next 2Y4.22%
Revenue Next 3Y4.02%
Revenue Next 5Y3.97%
EBIT growth 1Y3.66%
EBIT growth 3Y-4.53%
EBIT growth 5Y6.15%
EBIT Next Year19.71%
EBIT Next 3Y10.03%
EBIT Next 5YN/A
FCF growth 1Y-21.18%
FCF growth 3Y0.98%
FCF growth 5Y-1.08%
OCF growth 1Y-16.04%
OCF growth 3Y5.75%
OCF growth 5Y3.52%

HENRY SCHEIN INC / HSIC FAQ

What is the ChartMill fundamental rating of HENRY SCHEIN INC (HSIC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HSIC.


What is the valuation status of HENRY SCHEIN INC (HSIC) stock?

ChartMill assigns a valuation rating of 5 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.


Can you provide the profitability details for HENRY SCHEIN INC?

HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.


What are the PE and PB ratios of HENRY SCHEIN INC (HSIC) stock?

The Price/Earnings (PE) ratio for HENRY SCHEIN INC (HSIC) is 15.21 and the Price/Book (PB) ratio is 2.67.


What is the earnings growth outlook for HENRY SCHEIN INC?

The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 9.23% in the next year.